| COVID-19 Vaccine |
1 |
1 |
| Immunization |
0 |
0.87 |
| COVID-19 |
0 |
0.85 |
| Patient Safety |
0 |
0.9 |
| Vaccines |
0 |
0.75 |
| Adverse Effects |
0 |
0.7 |
| Fellowship |
0 |
0.29 |
| Arthritis |
0 |
0.14 |
| Id Reaction |
0 |
0.14 |
| Severe Acute Respiratory Syndrome |
0 |
0.14 |
| Dermatitis |
0 |
0.13 |
| Acute Respiratory Distress Syndrome |
0 |
0.1 |
| Connective Tissue Disease |
0 |
0.1 |
| Systemic Lupus Erythematosus |
0 |
0.08 |
| Fatigue |
0 |
0.07 |
| Grant |
0 |
0.07 |
| Immunocompromise |
0 |
0.07 |
| Lupus |
0 |
0.07 |
| Myositis |
0 |
0.07 |
| Pain |
0 |
0.07 |
| Tissue |
0 |
0.07 |
| Pain Management |
0 |
0.05 |